Biotech Values

[DewDiligence]

COR addendum:

I intended to mention this in my prior post on the COR CC but I forgot. It came out in the Q&A session of the CC that Dr. Deadwyler’s sleep-dep submission to an unnamed journal was withdrawn due to an editorial disagreement.

This is most likely a trivial matter, but there has to be at least a slim chance that it is not. If it turned out that there was any hint of impropriety in Dr. Deadwyler’s research, that would be very bad news for COR.

p.s. I’m surprised no one replied to my prior post concerning the delay in the start of phase-2b trials. Perhaps this was discussed on the COR board and I missed it.